1,110 filings
Page 2 of 56
8-K
4jxviagiii1ksyabqnd
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm
8-K
v0cz8lceoy6
31 Oct 23
Pfizer Reports Third-Quarter 2023 Results
8:04am
8-K
6axriv
13 Oct 23
Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance
5:30pm
8-K
3glvsu
1 Aug 23
Pfizer Reports Second-Quarter 2023 Results
8:09am
8-K
lxrcbwx
27 Jul 23
Departure of Directors or Certain Officers
4:11pm
8-K
s2pw2m4vfn1i1ui
19 May 23
Other Events
4:26pm
424B5
v7vkkfjpa
18 May 23
Prospectus supplement for primary offering
4:37pm
FWP
3t12mh5y1ckqv
16 May 23
Free writing prospectus
9:31pm
424B3
hvjg8 40j
15 May 23
Prospectus supplement
7:50am
POSASR
2ywsddmu
15 May 23
Automatic shelf registration (post-effective amendment)
7:40am
8-K
tr65ei
15 May 23
Other Events
6:25am
8-K
bvf0hrusuco5v
2 May 23
Pfizer Reports First-Quarter 2023 Results
8:05am
8-K
hrtj jii8s42ly0b
1 May 23
Submission of Matters to a Vote of Security Holders
9:39am
PX14A6G
i6v5pl9
12 Apr 23
Letter to shareholders
9:04am
DEFA14A
dyv1cow fw
10 Apr 23
Additional proxy soliciting materials
10:43am
DEFA14A
4x1d7o t0o
10 Apr 23
Additional proxy soliciting materials
10:40am
PX14A6G
0pk9b8
4 Apr 23
Letter to shareholders
11:46am